Theracryf Plc
TCF.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | £4,613 | £1,443 | £2,062 | £2,337 |
| - Cash | £1,455 | £2,109 | £1,196 | £2,004 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £3,158 | -£666 | £866 | £333 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | -£4 | -£862 | -£35 | -£5 |
| % Margin | – | – | – | – |
| EBITDA | -£1,309 | -£840 | -£1,210 | -£2,102 |
| % Margin | – | – | – | – |
| Net Income | -£1,313 | -£696 | -£1,245 | -£1,678 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0.001 | -0.005 | -0.006 |
| % Growth | 100% | 75.6% | 26.2% | – |
| Operating Cash Flow | -£699 | -£980 | -£1,392 | -£1,724 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | -£699 | -£980 | -£1,392 | -£1,724 |